On this PhLAG episode the team discuss the following topics:
1. FDA Pharmacy Compounding Advisory Committee - After almost three years the FDA will be evaluating four (4) APIs for inclusion on the 503A positive list.
2. The Berkeley Research Group's Report - A white paper analyzing the FDA's commissioned report on cBHT from NASEM
3. cBHT Content Creator - APC has pulled together a uniform messaging for your patients and pharmacy. A "how-to" on getting your story out and having it get noticed.
4. MOU Update - The FDA has posted a list of frequently asked questions that should have you and your state Board of Pharmacy concerned.
Listen to any episode whenever and wherever you are:
Spotify: spoti.fi/3chILp...
Apple Podcast: apple.co/3esHjTC
Google Podcast: bit.ly/3vczE1s
Send your PhLAG related questions to: govaffairs@medisca.com
Follow Medisca here:
LinkedIn: bit.ly/35wpKwn
Facebook: bit.ly/38zL8CZ
Негізгі бет PhLAG 2021 Ep.5
Пікірлер